Mr. Swiss is a recognized specialist in the area of pharmaceutical and chemical patents. His practice involves patent prosecution as well as patent and technology transfer agreements in the pharmaceutical, chemistry, and biotechnology areas. Mr. Swiss has counseled both early-stage ventures and large pharmaceutical companies on patent strategy for the protection of foundation technologies. He has drafted and prosecuted patent applications for complex pharmaceuticals, including anti-inflammatory compounds, antibiotics, carbohydrates, and compounds used in the treatment of Alzheimer's disease. In addition, Mr. Swiss has worked on the chemical aspects of medical devices, including methods directed to vascular embolization using chemical compositions delivered via catheters, and skin protection compositions.
"We are delighted that Jerry has joined the firm," said Gladys Monroy, co-chair of the firm's Patent Group. "Jerry's expertise in chemistry and pharmaceuticals complements the firm's capabilities in biotech and medical devices. His arrival further strengthens our thriving life sciences practice."
Keith Wetmore, Chair of the firm, noted, "Starting with the additions of Tom Ciotti, Kate Murashige and Gladys Monroy over a decade ago, the firm has assembled a world-class patent prosecution practice on both the East and West Coasts. Jerry's arrival is another milestone."
Gerald Swiss commented, "I have admired Morrison & Foerster's patent practice for a number of years. I am excited to have the chance to join the team. I am particularly excited because of the opportunities presented as numerous biotech companies expand into the small molecule aspects of pharmaceutical chemistry."
Mr. Swiss received his law degree cum laude from Seton Hall Law School in 1981, his M.S. degree in Chemistry from the University of Chicago in 1976, and his B.S. degree in Chemistry cum laude from the University of Notre Dame in 1975. He began his career handling chemical and pharmaceutical research work at Schering Plough, specializing in the synthesis of small organic molecules as pharmaceutical entities. His legal career encompassed both contract and patent work for the Chevron Research Company and as a patent attorney for Syntex (U.S.A.) Inc. During his tenure as a contract attorney at Chevron Research Company, Mr. Swiss worked on a variety of matters involving complex license agreements and joint venture agreements. He is registered to practice before the U.S. Patent and Trademark Office and is admitted to practice in California and New Jersey.
Morrison & Foerster's Patent Group has 80 attorneys and 10 patent agents. The Patent Group represents major corporations, new technology ventures, universities and nonprofit research institutions in a wide range of patent and technology-related matters. Attorneys in the group are experts in a wide range of technologies including computers, software, mechanical devices, chemistry, and biological sciences.